The American Journal of Managed Care

Subcutaneous Tocilizumab Superior to Methotrexate in Chinese Patients With RA

Subcutaneous tocilizumab, alone or with methotrexate, showed superior efficacy over methotrexate monotherapy in treating rheumatoid arthritis in Chinese patients. The trial demonstrated higher ACR20 ...
Medscape

Tocilizumab, Alone or With Methotrexate, Potent in Active RA

Subcutaneous tocilizumab, either as monotherapy or in combination with methotrexate, demonstrated greater efficacy than methotrexate alone and was well tolerated in patients with active rheumatoid ...
The American Journal of Managed Care

FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS

The FDA has eliminated REMS for BCMA- and CD19-directed CAR T-cell therapies, improving access and reducing provider burden. Hospitals no longer need special certification or immediate access to ...
Medical Dialogues

CDSCO Clears Over 100 rDNA Drugs and Biologics Between 2020-25, Boosting Access to Advanced Therapies

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...